This study investigates pancreatic cancer. It looks at how safe and tolerable the investigational medication is when used with certain chemotherapy treatments.
The study evaluates safety and effectiveness. It checks how well the investigational medication works with chemotherapy in treating pancreatic cancer.
- Who can participate: Adults with inoperable locally advanced or metastatic pancreatic ductal adenocarcinoma can participate. Participants must have measurable lesions and good overall health according to specific medical criteria.
- Study details: Participants will receive an investigational medication combined with chemotherapy. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand